About This Study
The purpose of this study is to learn more about a new medicine called mRNA-2808 for people with multiple myeloma, a type of blood cancer. This medicine helps teach your immune system how to find and kill cancer cells. The goal is to see if the medicine is safe and to find the best dose. Researchers will also study how it affects the cancer and the body.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- Use of Study Health Plans
- After Study Follow-Up Activities
- Review of Medical History
- Physical Examinations
- Phone Calls and/or Emails
- Study Visits and Consultations
- Laboratory and Imaging Tests
- Specimen Sample Collection
Age & Gender
- 18 - 100+ years old
- Female
- Male
Language
- This study enrolls English and Spanish speakers
Additional Study Information
- Compensation Offered
- No reimbursement offered
Study Locations
- Greater Charlotte, NC